BIOSPECIFICS TECHNOLOGIES CORP
10QSB, EX-27, 2000-09-15
PHARMACEUTICAL PREPARATIONS
Previous: BIOSPECIFICS TECHNOLOGIES CORP, 10QSB, 2000-09-15
Next: DIGITRAN SYSTEMS INC /DE, NT 10-Q, 2000-09-15



<TABLE> <S> <C>

<ARTICLE>                     5

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                                      Jan-31-2001
<PERIOD-START>                                         Feb-01-1999
<PERIOD-END>                                           Jul-31-2000
<CASH>                                                   3,157,040
<SECURITIES>                                               872,781
<RECEIVABLES>                                            1,009,830
<ALLOWANCES>                                                     0
<INVENTORY>                                              1,671,900
<CURRENT-ASSETS>                                           208,057
<PP&E>                                                   4,215,430
<DEPRECIATION>                                           1,374,547
<TOTAL-ASSETS>                                          10,662,755
<CURRENT-LIABILITIES>                                            0
<BONDS>                                                          0
                                            0
                                                      0
<COMMON>                                                     4,891
<OTHER-SE>                                              11,582,684
<TOTAL-LIABILITY-AND-EQUITY>                            10,662,755
<SALES>                                                  3,503,394
<TOTAL-REVENUES>                                         3,503,394
<CGS>                                                    1,243,357
<TOTAL-COSTS>                                            1,243,357
<OTHER-EXPENSES>                                           776,630
<LOSS-PROVISION>                                                 0
<INTEREST-EXPENSE>                                           2,845
<INCOME-PRETAX>                                             24,501
<INCOME-TAX>                                                 2,900
<INCOME-CONTINUING>                                         21,501
<DISCONTINUED>                                                   0
<EXTRAORDINARY>                                                  0
<CHANGES>                                                        0
<NET-INCOME>                                                     0
<EPS-BASIC>                                                   0.01
<EPS-DILUTED>                                                 0.01


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission